Scarica l'app Stockscreener
229.89
0.48%
1.10
Dopo l'orario di chiusura:
229.90
0.01
+0.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$228.79
Aprire:
$229.46
Volume 24 ore:
1.74M
Relative Volume:
0.30
Capitalizzazione di mercato:
$406.30B
Reddito:
$59.64B
Utile/perdita netta:
$2.36B
Rapporto P/E:
173.46
EPS:
1.3253
Flusso di cassa netto:
$19.68B
1 W Prestazione:
+2.49%
1M Prestazione:
+0.17%
6M Prestazione:
+23.90%
1 anno Prestazione:
+27.72%
Intervallo 1D:
$228.98
$230.80
Intervallo di 1 settimana:
$222.35
$230.80
Portata 52W:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Nome
Abbvie Inc
Settore
Industria
Telefono
(847) 932-7900
Indirizzo
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Confronta ABBV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
229.89 | 404.36B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
1,076.98 | 959.14B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.78 | 495.78B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
138.88 | 266.96B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
106.45 | 260.71B | 63.90B | 19.05B | 13.05B | 7.5596 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-11-04 | Downgrade | DZ Bank | Buy → Hold |
| 2025-10-14 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-01 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-09-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2025-08-12 | Ripresa | Piper Sandler | Overweight |
| 2025-08-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-12-05 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-04 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-05-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-12-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-10-30 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-09-29 | Iniziato | Raymond James | Outperform |
| 2023-07-25 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-04-05 | Downgrade | Argus | Buy → Hold |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2023-02-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Aggiornamento | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-11-08 | Downgrade | Societe Generale | Buy → Hold |
| 2022-08-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Iniziato | SVB Leerink | Underperform |
| 2022-05-06 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2022-02-28 | Downgrade | UBS | Buy → Neutral |
| 2022-02-03 | Reiterato | BMO Capital Markets | Outperform |
| 2022-02-03 | Reiterato | Barclays | Equal Weight |
| 2022-02-03 | Reiterato | BofA Securities | Neutral |
| 2022-02-03 | Reiterato | Goldman | Neutral |
| 2022-01-13 | Iniziato | Redburn | Buy |
| 2022-01-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-11-23 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-06-23 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Aggiornamento | Argus | Hold → Buy |
| 2020-05-18 | Ripresa | BofA/Merrill | Neutral |
| 2020-05-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Ripresa | Morgan Stanley | Overweight |
| 2020-04-20 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Downgrade | Societe Generale | Buy → Hold |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Reiterato | Cowen | Outperform |
| 2019-09-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-08-20 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-04-29 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
Mostra tutto
Abbvie Inc Borsa (ABBV) Ultime notizie
AbbVie Stock (ABBV) Before the Market Opens Dec. 26, 2025: Today’s News, Earnings Outlook, Dividend Update, and Analyst Forecasts - ts2.tech
AbbVie (ABBV) Stock on Dec. 25, 2025: After-Hours Check, Today’s Headlines, and What to Watch Before the Dec. 26 Open - ts2.tech
Swedbank AB Buys 40,781 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Brookstone Capital Management - MarketBeat
AbbVie Stock (ABBV) After Hours on Dec. 24, 2025: What Happened Today and What to Know Before the Next Market Open - ts2.tech
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching - ts2.tech
Top Stock Reports for AbbVie, Coca-Cola & Chevron - Yahoo Finance
Check out AbbVie's stock price (ABBV-CA) in real time - CNBC
AbbVie Inc. $ABBV Shares Sold by Yousif Capital Management LLC - MarketBeat
Trust Co. of Vermont Buys 12,456 Shares of AbbVie Inc. $ABBV - MarketBeat
Farther Finance Advisors LLC Has $11.04 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Exchange Traded Concepts LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Anderson Hoagland & Co. - MarketBeat
AbbVie (ABBV) Stock After Hours Today (Dec. 23, 2025): Key News, Forecasts, and What to Watch Before the Market Opens Dec. 24 - ts2.tech
AbbVie (ABBV) Stock News Today, Dec. 23, 2025: Beyond Botox Pipeline Push, Analyst Targets, and What to Watch Next - ts2.tech
AbbVie, Neurocrine End One Orilissa Patent Case Against Hetero - Bloomberg Law News
ABBV vs. AZN: Which Pharma Stock is the Better Investment Now? - Yahoo Finance
Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D - Pharma Voice
Top 5 US Healthcare Stocks By Market Value - Stocktwits
OFI Invest Asset Management Purchases 102,463 Shares of AbbVie Inc. $ABBV - MarketBeat
HBK Sorce Advisory LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Goelzer Investment Management Inc. - MarketBeat
Berger Financial Group Inc Has $4.64 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock After Hours (ABBV): Shares Dip After the Bell on Dec. 22, 2025 — Key News, Forecasts, and What to Watch Before Tuesday’s Open - ts2.tech
What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders - Yahoo Finance
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus - ts2.tech
3 Dividend Growth Stocks Analysts Are Upgrading for 2026 - Investing.com
Wedge Capital Management L L P NC Sells 35,033 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is CHICAGO TRUST Co NA's 8th Largest Position - MarketBeat
Charles Schwab Trust Co Acquires 15,502 Shares of AbbVie Inc. $ABBV - MarketBeat
11,477 Shares in AbbVie Inc. $ABBV Purchased by Corsicana & Co. - MarketBeat
CCM Investment Advisers LLC Decreases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts - ts2.tech
AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades - ts2.tech
Meadowbrook Wealth Management LLC Purchases New Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by BDF Gestion - MarketBeat
AbbVie Stock (ABBV) News Today: Drug-Pricing Deal Watch, Skyrizi/Rinvoq Momentum, and Fresh Wall Street Forecasts (Dec. 20, 2025) - ts2.tech
U.S. Capital Wealth Advisors LLC Decreases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Voya Investment Management LLC Acquires 449,794 Shares of AbbVie Inc. $ABBV - MarketBeat
Franklin Street Advisors Inc. NC Increases Holdings in AbbVie Inc. $ABBV - MarketBeat
MFG Wealth Management Inc. Acquires Shares of 6,431 AbbVie Inc. $ABBV - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Aug Update: Why analysts raise outlook for AbbVie Inc. (Common Stock) (4AB0) stock2025 Trading Recap & Real-Time Stock Entry Alerts - Улправда
AbbVie Stock (ABBV) After Hours on Dec. 19, 2025: What to Know Before the Next Market Open - ts2.tech
AbbVie (NYSE:ABBV) Shares Up 2.1%Still a Buy? - MarketBeat
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc - GuruFocus
AbbVie (ABBV) Gets a Buy from Evercore ISI - The Globe and Mail
Is AbbVie Inc. stock supported by free cash flowJuly 2025 Momentum & Community Consensus Trade Signals - DonanımHaber
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report - Asianet Newsable
Abbvie Inc Azioni (ABBV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):